Abstract
Mutations in the GIGYF2 gene at the PARK11 locus have recently been reported in Parkinson’s disease (PD). However, the pathogenicity of some of these mutations has been debated. We conducted a comprehensive genetic analysis of the entire GIGYF2 gene in a cohort of young onset and familial PD patients, followed up with screening of specific variants in a separate group of PD and healthy controls. A total of 850 study subjects [450 Parkinson’s disease (PD) patients and 400 controls] from two Asian countries were included. Our analysis revealed 17 variants distributed across the entire GIGYF2 gene. Ten of these were novel variants out of which eight were non-synonymous (all heterozygous). Out of these eight, half were novel polymorphic variants (0.2–2%) whereas four were novel non-synonymous variants which were not detected in healthy controls. The seven PD patients with non-synonymous variants had a mean age and age at onset of 55.3 and 50.9 years. All had typical features of PD and only one had a positive family history. The collective frequency of these non-synonymous variants was higher in PD compared to controls (1.6 vs. 0%, P = 0.016, relative risk 1.9, 95% CI 1.2, 1.9). None of the previously reported pathogenic mutations in Italian and French patients were present in our cohort. Our data suggest that GIGYF2 is unlikely to play a major role in our Asian populations. Rare non-synonymous variants appeared to be enriched in our PD patients compared to healthy controls. However, in vivo functional studies and segregation analysis in large pedigrees will be needed to determine if these single heterozygous variants represent rare mutations, risk alleles or benign polymorphisms.
Similar content being viewed by others
References
Bonifati V, Rizzu P, van Baren MJ et al (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256–259
Bras J, Simón-Sánchez J, Federoff M et al (2009) Lack of replication of association between GIGYF2 variants and Parkinson disease. Hum Mol Genet 18(2):341–346
Giovannone B, Lee E, Laviola L, Giorgino F, Cleveland KA, Smith RJ (2003) Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling. J Biol Chem 278(34):31564–31573
Kitada T, Asakawa S, Hattori N et al (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605–608
Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE (2007) Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol 6(7):652–662
Lautier C, Goldwurm S, Dürr A et al (2008) Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. Am J Hum Genet 82(4):822–833
Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, Vassilatis DK (2003) Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 33(1):85–89
Leroy E, Boyer R, Auburger G et al (1998) The ubiquitin pathway in Parkinson’s disease. Nature 395:451–452
Nichols WC, Kissell DK, Pankratz N et al (2009) For the Parkinson Study Group—PROGENI Investigators. Variation in GIGYF2 is not associated with Parkinson disease. Neurology [Epub ahead of print]
Paisan-Ruiz C, Jain S, Evans EW et al (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron 44:595–600
Paisan-Ruiz C, Bhatia KP, Li A et al (2008) Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol (in press). doi:10.1002/ana.21415
Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276:2045–2047
Ramirez A, Heimbach A, Grundemann J et al (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38:1184–1191
Sutherland GT, Siebert GA, Newman JR et al (2008) Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson’s disease. Mov Disord [Epub ahead of print]
Tan EK, Jankovic J (2006) Genetic testing in Parkinson disease: promises and pitfalls. Arch Neurol 63(9):1232–1237
Tan EK, Skipper LM (2007) Pathogenic mutations in Parkinson disease. Hum Mutat 28(7):641–653
Tan EK, Tong J, Fook-Chong S et al (2007) Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients. Arch Neurol 64(7):1056–1058
Valente EM, Abou-Sleiman PM, Caputo V et al (2004) Hereditary early-onset Parkinson’s disease caused by mutations in PINK1. Science 304:1158–1160
Vilariño-Güell C, Ross OA, Soto AI et al (2009) Reported mutations in GIGYF2 are not a common cause of Parkinson’s disease. Mov Disord [Epub ahead of print]
Zimprich A, Biskup S, Leitner P et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44(4):601–607
Zimprich A, Schulte C, Reinthaler E et al (2009) PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson’s disease. Parkinsonism Relat Disord [Epub ahead of print]
Acknowledgments
The study was supported by Singapore Millennium Foundation, National Medical Research Council, Duke-NUS Graduate Medical School, Singapore General Hospital, SingHealth and Taiwan National Science Council (NSC96-2628-B-002-103-MY2). The authors thank Tang SS for assistance in the protein alignment analysis. The lead author had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tan, EK., Lin, CH., Tai, CH. et al. Non-synonymous GIGYF2 variants in Parkinson’s disease from two Asian populations. Hum Genet 126, 425–430 (2009). https://doi.org/10.1007/s00439-009-0678-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-009-0678-x